4-PrO-MET
Pharmaceutical compound
From Wikipedia, the free encyclopedia
4-PrO-MET, also known as 4-propionyloxy-N-methyl-N-ethyltryptamine or as O-propionyl-4-HO-MET, is a psychedelic drug of the tryptamine and 4-hydroxytryptamine families related to 4-AcO-DMT (psilacetin).[1][2] It is thought to be a prodrug of 4-HO-MET (metocin) similarly to 4-AcO-MET (metacetin).[1][2] 4-PrO-MET was encountered online as a novel designer drug in August or September 2025.[1][2] It is anecdotally claimed to produce more intense psychedelic visuals than psilocin (4-HO-DMT) but to be "less heavy" and to have good tolerability.[1] 4-PrO-MET is not an explicitly controlled substance in the United States[3] or in Canada.[4]
Other names4-Propionyloxy-MET; 4-Propionyloxy-N-methyl-N-ethyltryptamine; O-Propionyl-4-HO-MET; O-Propionylmetocin
ATC code
- None
| Clinical data | |
|---|---|
| Other names | 4-Propionyloxy-MET; 4-Propionyloxy-N-methyl-N-ethyltryptamine; O-Propionyl-4-HO-MET; O-Propionylmetocin |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C16H22N2O2 |
| Molar mass | 274.364 g·mol−1 |
| 3D model (JSmol) | |
| |
| |